Having a system, or research subject database registry, to proactively detect and prevent duplicate subjects and other protocol violations has become a well recognized and important step to protect the data quality and improve research subject safety. This is NOT limited to phase 1 healthy volunteer studies. This happens with significant frequency across multiple therapeutic …
Duplicate subjects and preventable protocol violations can easily be prevented up-front at the time of screening using the global research subject database registry Verified Clinical Trials (VCT). The protections continue for the entire duration fo the study including the specific washout criteria. VCT has data that routinely demonstrates double digit preventable protocol violations. Professional research …
